WEBINAR
Adapting to Decentralized Clinical Research: Practical Lessons on Oversight and Quality
June 11, 2020

In these challenging times, clinical research that isn't COVID-related is almost entirely stalled. With travel restrictions, conventional research sites have limited or no enrollment. Companies need a path to continuing their studies.

In this webinar we will discuss practical advice on decentralizing clinical trials. Decentralized clinical trials allow patients to participate far beyond the reach of conventional sites -- meaning at-home, via telemedicine, and in local community doctor's offices that are still seeing patients.

The webinar pays special attention to ensuring study quality. While techniques like telemedicine and ePRO are widely understood, ensuring FDA-submittable quality and adhering to GCP are more challenging in a virtual study, and an area of unique experience for Curebase.

Specific topics include:

  • Structuring your site
  • Investigator oversight
  • Ensuring endpoint quality
  • Consenting
  • Validation
  • Source data
  • Patient engagement
  • Monitoring
  • Managing safety events
  • IRB engagement

About Curebase
Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Our vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools Curebase’s has designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community.  

This starts with Curebase’s leading decentralized clinical trial software platform that is an all-in-one, purpose built eClinical software system, with every tool needed to manage and collect data for decentralized clinical trials. This includes ePRO, eCOA, eConsent, Telemedicine, and much more. Curebase also offers a virtual research site, complete with virtual investigators, research coordinators, mobile nursing, and other healthcare staff that administer care to patients where convenient for them, just like any other research site, but with the ability to stand up anywhere and with greater patient convenience and reach. Notably, Curebase is the pioneer of the “BYOP” or Bring Your Own Physician model, allowing patients to use their own doctors to participate in clinical trials. 

We are reinventing a $45B market, enabling drug and device companies to increase the volume, quality, and speed of data collection regardless of patients’ physical location. COVID-19 tailwinds have created massive demand for telemedicine and home-based trials, with two new FDA guidance letters and industry-wide adoption of remote remote research that will only accelerate in the years to come. You can learn more about Curebase and our next stage of growth in Crunchbase, Fierce Biotech, and MedCity News!

You can learn more in a 1-1 meeting with Curebase.
Request a Meeting
Or, subscribe to our blog and other educational updates.
Reserve your spot today!

Curebase Webinar

Adapting to Decentralized Clinical Research: Practical Lessons on Oversight and Quality

June 11, 2020
Featured speaker:
Kai Langel
Director, Janssen Clinical Innovation
Kai Langel
Director, Janssen Clinical Innovation
June 11, 2020
free
About the Webinar
Collaborate with patient representatives for software configuration and user testing
Assist patients along their treatment journey with patient-centric software and communication tools
Closely monitor data in real-time to gain actionable insights into the patient experience

In these challenging times, clinical research that isn't COVID-related is almost entirely stalled. With travel restrictions, conventional research sites have limited or no enrollment. Companies need a path to continuing their studies.

In this webinar we will discuss practical advice on decentralizing clinical trials. Decentralized clinical trials allow patients to participate far beyond the reach of conventional sites -- meaning at-home, via telemedicine, and in local community doctor's offices that are still seeing patients.

The webinar pays special attention to ensuring study quality. While techniques like telemedicine and ePRO are widely understood, ensuring FDA-submittable quality and adhering to GCP are more challenging in a virtual study, and an area of unique experience for Curebase.

Specific topics include:

  • Structuring your site
  • Investigator oversight
  • Ensuring endpoint quality
  • Consenting
  • Validation
  • Source data
  • Patient engagement
  • Monitoring
  • Managing safety events
  • IRB engagement

About Curebase
Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Our vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools Curebase’s has designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community.  

This starts with Curebase’s leading decentralized clinical trial software platform that is an all-in-one, purpose built eClinical software system, with every tool needed to manage and collect data for decentralized clinical trials. This includes ePRO, eCOA, eConsent, Telemedicine, and much more. Curebase also offers a virtual research site, complete with virtual investigators, research coordinators, mobile nursing, and other healthcare staff that administer care to patients where convenient for them, just like any other research site, but with the ability to stand up anywhere and with greater patient convenience and reach. Notably, Curebase is the pioneer of the “BYOP” or Bring Your Own Physician model, allowing patients to use their own doctors to participate in clinical trials. 

We are reinventing a $45B market, enabling drug and device companies to increase the volume, quality, and speed of data collection regardless of patients’ physical location. COVID-19 tailwinds have created massive demand for telemedicine and home-based trials, with two new FDA guidance letters and industry-wide adoption of remote remote research that will only accelerate in the years to come. You can learn more about Curebase and our next stage of growth in Crunchbase, Fierce Biotech, and MedCity News!

You can learn more in a 1-1 meeting with Curebase
Book a meeting
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
335 S Van Ness Ave, San Francisco, CA,
94103-3627, United States

Register for Webinar

We'd love to hear from you, whether a Sponsor interested in running a study with us, a provider looking to get involved in clinical research, or patients interested in our studies. Fill out your information below and one of our team members will be in touch.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.